{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:18:13Z","timestamp":1791591493774,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":187,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD081197"],"award-info":[{"award-number":["R01 HD081197"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.gastha.2025.100741","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:03:48Z","timestamp":1752620628000},"page":"100741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fecal Microbiota Transplantation Induces Sustained Gut Microbiome Changes in Pediatric Ulcerative Colitis: A Combined Randomized and Open-Label Study"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8248-3649","authenticated-orcid":false,"given":"Jessica","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesamedin","family":"Hakimjavadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Parsana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikar","family":"Chamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Michail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ibd.21383","article-title":"Acute severe ulcerative colitis in children: a systematic review","volume":"17","author":"Turner","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"33-34","key":"10.1016\/j.gastha.2025.100741_bib2","first-page":"564","article-title":"Ulcerative colitis\u2014diagnostic and therapeutic algorithms","volume":"117","author":"Kucharzik","year":"2020","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib3","first-page":"32","article-title":"Increased lifetime risk of intestinal complications and extraintestinal manifestations in crohn's disease and ulcerative colitis","volume":"18","author":"Lichtenstein","year":"2022","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2025.100741_bib4","first-page":"619","article-title":"Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007\u20132016","volume":"26","author":"Ye","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.gastha.2025.100741_bib5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gastha.2025.100741_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1159\/000529591","article-title":"The role of fecal microbiota transplantation in the induction of remission in ulcerative colitis","volume":"41","author":"Saleh","year":"2023","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.gastha.2025.100741_bib7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"issue":"472","key":"10.1016\/j.gastha.2025.100741_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8914","article-title":"Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome","volume":"10","author":"Vich Vila","year":"2018","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.gastha.2025.100741_bib9","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/ismej.2017.44","article-title":"Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation","volume":"11","author":"Fuentes","year":"2017","journal-title":"ISME J"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-016-0294-z","article-title":"The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation","volume":"8","author":"Langdon","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.gastha.2025.100741_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.818902","article-title":"Gut microbiota is a potential biomarker in inflammatory bowel disease","volume":"8","author":"Guo","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"issue":"10075","key":"10.1016\/j.gastha.2025.100741_bib13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.gastha.2025.100741_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: a systematic review and meta-analysis of double-blind randomized controlled trials","volume":"29","author":"El Hage Chehade","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.gastha.2025.100741_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/MPG.0b013e318292fa0d","article-title":"Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis","volume":"56","author":"Kunde","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.gastha.2025.100741_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.gastro.2021.04.067","article-title":"Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects","volume":"161","author":"Pai","year":"2021","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gastha.2025.100741_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiy133","article-title":"Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients","volume":"94","author":"Nusbaum","year":"2018","journal-title":"FEMS Microbiol Ecol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib18","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1038\/s41598-022-07995-7","article-title":"16S rRNA and metagenomic shotgun sequencing data revealed consistent patterns of gut microbiome signature in pediatric ulcerative colitis","volume":"12","author":"Zuo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2025.100741_bib19","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/gmb.2023.15","article-title":"Gut metabolomic profiles in paediatric ulcerative colitis patients prior to and after receiving faecal microbiota transplants","volume":"4","author":"Hosseini","year":"2023","journal-title":"Gut Microbiome"},{"issue":"4","key":"10.1016\/j.gastha.2025.100741_bib20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ajg.2010.481","article-title":"Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the porto IBD working group of ESPGHAN","volume":"106","author":"Turner","year":"2011","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"10.1016\/j.gastha.2025.100741_bib21","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"10","author":"Feagan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.gastha.2025.100741_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/apt.13366","article-title":"Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data","volume":"42","author":"Costello","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2025.100741_bib23","article-title":"nf-Core\/taxprofiler: highly parallelised and flexible pipeline for metagenomic taxonomic classification and profiling","author":"Stamouli","year":"2023","journal-title":"bioRxiv"},{"issue":"6285","key":"10.1016\/j.gastha.2025.100741_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.gastha.2025.100741_bib25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3389\/fmicb.2018.01274","article-title":"5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis","volume":"9","author":"Xu","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib26","article-title":"The role of bacteria in the pathogenesis of ulcerative colitis","volume":"2012","author":"Sasaki","year":"2012","journal-title":"J Signal Transduct"},{"issue":"9","key":"10.1016\/j.gastha.2025.100741_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00535-016-1220-2","article-title":"Indole compounds may be promising medicines for ulcerative colitis","volume":"51","author":"Sugimoto","year":"2016","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2025.100741_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000444217","article-title":"Clinical efficacy and safety of oral qing-dai in patients with ulcerative colitis: a single-center open-label prospective study","volume":"93","author":"Sugimoto","year":"2016","journal-title":"Digestion"},{"issue":"5","key":"10.1016\/j.gastha.2025.100741_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/microorganisms10050930","article-title":"Production of indole and indole-related compounds by the intestinal microbiota and consequences for the host: the good, the bad, and the ugly","volume":"10","author":"Tennoune","year":"2022","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.gastha.2025.100741_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/JPER.22-0205","article-title":"Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism","volume":"94","author":"Lin","year":"2023","journal-title":"J Periodontol"},{"issue":"4","key":"10.1016\/j.gastha.2025.100741_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100741_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fgene.2015.00081","article-title":"Mucin glycan foraging in the human gut microbiome","volume":"6","author":"Tailford","year":"2015","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.gastha.2025.100741_bib33","doi-asserted-by":"crossref","first-page":"fiw191","DOI":"10.1093\/femsec\/fiw191","article-title":"Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers","volume":"92","author":"Duranti","year":"2016","journal-title":"FEMS Microbiol Ecol"},{"issue":"8","key":"10.1016\/j.gastha.2025.100741_bib34","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/ismej.2012.6","article-title":"Microbes inside\u2014from diversity to function: the case of Akkermansia","volume":"6","author":"Belzer","year":"2012","journal-title":"ISME J"},{"key":"10.1016\/j.gastha.2025.100741_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fcimb.2018.00281","article-title":"Alterations in the abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects","volume":"8","author":"Lopez-Siles","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.gastha.2025.100741_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40168-018-0443-2","article-title":"Characterizing oral microbial communities across dentition states and colonization niches","volume":"6","author":"Mason","year":"2018","journal-title":"Microbiome"},{"issue":"10","key":"10.1016\/j.gastha.2025.100741_bib37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41564-022-01224-7","article-title":"Inflammation-associated nitrate facilitates ectopic colonization of oral bacterium Veillonella parvula in the intestine","volume":"7","author":"Rojas-Tapias","year":"2022","journal-title":"Nat Microbiol"},{"issue":"3","key":"10.1016\/j.gastha.2025.100741_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn's disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.gastha.2025.100741_bib39","first-page":"673","article-title":"Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis","volume":"104","author":"Ho","year":"2009","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"3","key":"10.1016\/j.gastha.2025.100741_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00365521.2019.1585939","article-title":"Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated \u2013 an open-label pilot study","volume":"54","author":"Cold","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib41","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2180-8-79","article-title":"Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis","volume":"8","author":"Scanlan","year":"2008","journal-title":"BMC Microbiol"},{"issue":"4","key":"10.1016\/j.gastha.2025.100741_bib43","first-page":"13","article-title":"Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease","volume":"91","author":"Danilova","year":"2019","journal-title":"Ter Arkh"},{"issue":"8","key":"10.1016\/j.gastha.2025.100741_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/1751-2980.12756","article-title":"Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota","volume":"20","author":"Huang","year":"2019","journal-title":"J Dig Dis"},{"issue":"8","key":"10.1016\/j.gastha.2025.100741_bib45","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000224","article-title":"Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes","volume":"11","author":"Li","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastha.2025.100741_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1015890","article-title":"Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn's disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets","volume":"12","author":"Khorsand","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"Supplement_1","key":"10.1016\/j.gastha.2025.100741_bib47","article-title":"P1238 exploring the role of Klebsiella variicola and Klebsiella pneumoniae in pediatric ulcerative colitis pathogenesis","volume":"18","author":"Arjomand","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastha.2025.100741_bib48","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.2147\/JIR.S334581","article-title":"Gut microbiota contributes to host defense against Klebsiella pneumoniae-induced liver abscess","volume":"14","author":"Zheng","year":"2021","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.gastha.2025.100741_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40168-021-01208-5","article-title":"Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers","volume":"10","author":"Coker","year":"2022","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.gastha.2025.100741_bib50","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s12602-022-09943-3","article-title":"Limosilactobacillus fermentum, current evidence on the antioxidant properties and opportunities to be exploited as a probiotic microorganism","volume":"14","author":"Paulino do Nascimento","year":"2022","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"9","key":"10.1016\/j.gastha.2025.100741_bib51","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/S0007114520001853","article-title":"Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study","volume":"124","author":"Zheng","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.gastha.2025.100741_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.742255","article-title":"Long-term efficacy of low-intensity single donor fecal microbiota transplantation in ulcerative colitis and outcome-specific gut bacteria","volume":"12","author":"Ren","year":"2021","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.gastha.2025.100741_bib53","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"8","author":"Murray","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.gastha.2025.100741_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gastha.2025.100741_bib55","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/gutjnl-2014-307240","article-title":"Effects of bowel cleansing on the intestinal microbiota","volume":"64","author":"Jalanka","year":"2015","journal-title":"Gut"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:31:08Z","timestamp":1764927068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572325001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2772572325001281"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100741","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal Microbiota Transplantation Induces Sustained Gut Microbiome Changes in Pediatric Ulcerative Colitis: A Combined Randomized and Open-Label Study","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"100741"}}